Clinical trial
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
NCT00120653 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Withdrawn
Key facts
| NCT number | NCT00120653 |
|---|---|
| Title | Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS) |
| Official title | Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Metoclopramide |
| Enrollment | 0 |
| Start date | Jul 14, 2005 |
| Completion | Jun 17, 2008 |
| First posted | Jul 18, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: